Details of the Drug Reposition

General Information of This Drug (ID: DM6ZXWY)

Drug Name
CAR.CD30 cells   DM6ZXWY
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neoplasm DISZKGEW 2A00-2F9Z Phase 1/2 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1/2 [1]
Immunoproliferative disorder DISKM0P1 2B32 Phase 1/2 [1]
Immune System disease DISPV68Z 4A01-4B41 Phase 1/2 [1]
Lymphatic disease DIS57XO9 BD9Z Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02663297) Administration of T Lymphocytes for Prevention of Relapse of Lymphomas